Enhancing global access to diabetes medicines: policy lessons from the HIV response
- PMID: 38128554
- DOI: 10.1016/S2213-8587(23)00359-5
Enhancing global access to diabetes medicines: policy lessons from the HIV response
Conflict of interest statement
CAB was supported by the Dutch Research Council's Rubicon programme (project number 452022313). MKA reported a past grant from Merck & Co to Emory University and past consulting fees from Bayer and Eli Lilly and Company outside the scope of the submitted work. All other authors declare no competing interests.
LinkOut - more resources
Full Text Sources
